Search

Kanji M Meghpara

age ~63

from Morris Plains, NJ

Also known as:
  • Kanji Meghpara
  • Melissa Meghpara
  • Kenji Meghpara
  • Kanji Meghara
  • Meghan Meghpara
60 Stockton Ct, Greystone Park, NJ 07950973-829-1872

Kanji Meghpara Phones & Addresses

  • 60 Stockton Ct, Morris Plains, NJ 07950 • 973-829-1872
  • Palo Alto, CA
  • Mountain View, CA
  • Parsippany, NJ
  • Lincoln, NE

Us Patents

  • Compositions With Hydrophilic Drugs In A Hydrophobic Medium

    view source
  • US Patent:
    20060222701, Oct 5, 2006
  • Filed:
    Mar 28, 2006
  • Appl. No.:
    11/391518
  • Inventors:
    Neema Kulkarni - Randolph NJ,
    Kanji Meghpara - Morris Plains NJ,
  • International Classification:
    A61K 9/48
  • US Classification:
    424451000
  • Abstract:
    In various embodiments of the present invention, a capsule is provided including a hydrophobic inner layer and at least one hydrophilic outer layer. The hydrophobic layer may include a hydrophilic component such as an active pharmaceutical ingredient (API) which may be fully encapsulated, partially encapsulated or part of an adsorption complex. Such capsules experience no or minimal cracking or breaking in the outer layer.
  • Compositions And Capsules With Stable Hydrophilic Layers

    view source
  • US Patent:
    20070134493, Jun 14, 2007
  • Filed:
    Dec 8, 2005
  • Appl. No.:
    11/296989
  • Inventors:
    Kanji Meghpara - Morris Plains NJ,
  • International Classification:
    B32B 9/00
  • US Classification:
    428402200
  • Abstract:
    Several embodiments of the present invention provide a capsule including a hydrophobic inner core layer and at least one hydrophilic outer layer. The outer layer may be seamless and may include at least one hygroscopic polyol and at least one polyol with a low hygroscopicity. The at least one outer layer may include at least one film or gel forming agent. Such capsules are stable and experience minimal or no degradation under accelerated stability conditions.
  • Sustained Release Paracetamol Formulations

    view source
  • US Patent:
    20140065213, Mar 6, 2014
  • Filed:
    May 4, 2012
  • Appl. No.:
    14/115896
  • Inventors:
    Dongzhou Liu - Parsippany NJ,
    Kanji Meghpara - Parsippany NJ,
  • Assignee:
    GlaxoSmithKline, LLC - Philadelphia
  • International Classification:
    A61K 9/24
    A61K 31/167
  • US Classification:
    424472, 514630
  • Abstract:
    The present invention is directed to twice daily sustained release pharmaceutical composition of paracetamol having an immediate release phase of paracetamol and a sustained release phase of paracetamol, said composition having unique and advantageous pharmacokinetic properties and a pharmaceutical composition comprising only a sustained release phase of paracetamol having unique and advantageous pharmacokinetic properties.

Resumes

Kanji Meghpara Photo 1

Principal Scientist At Glaxosmithkline Biologicals

view source
Position:
Principal Scientist at GlaxoSmithKline Biologicals, Principal Scientist at GlaxoSmithKline Consumer Healthcare Ltd., Principal Scientist at GSK CHRD, Principal Scientist at GSK Consumer Healthcare, Principal Scientist at GlaxoSmithKline
Location:
Greater New York City Area
Industry:
Pharmaceuticals
Work:
GlaxoSmithKline Biologicals
Principal Scientist

GlaxoSmithKline Consumer Healthcare Ltd. since 2008
Principal Scientist

GSK CHRD since 2008
Principal Scientist

GSK Consumer Healthcare since 2008
Principal Scientist

GlaxoSmithKline since 2008
Principal Scientist
Kanji Meghpara Photo 2

Kanji Meghpara

view source
Location:
Greater New York City Area
Industry:
Pharmaceuticals
Kanji Meghpara Photo 3

Kanji Meghpara

view source
Location:
Greater New York City Area
Industry:
Pharmaceuticals

Facebook

Kanji Meghpara Photo 4

Kanji Meghpara

view source

Get Report for Kanji M Meghpara from Morris Plains, NJ, age ~63
Control profile